NewSquare Capital’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
60
| – | – | ﹤0.01% | 1303 |
|
|
2025
Q1 | $1 | Hold |
60
| – | – | ﹤0.01% | 1156 |
|
|
2024
Q4 | $1 | Hold |
60
| – | – | ﹤0.01% | 912 |
|
|
2024
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 400 |
|
|
2024
Q2 | $2 | Hold |
60
| – | – | ﹤0.01% | 352 |
|
|
2024
Q1 | $5 | Hold |
60
| – | – | ﹤0.01% | 436 |
|
|
2023
Q4 | $6 | Hold |
60
| – | – | ﹤0.01% | 488 |
|
|
2023
Q3 | $14 | Hold |
60
| – | – | ﹤0.01% | 590 |
|
|
2023
Q2 | $16 | Hold |
60
| – | – | ﹤0.01% | 839 |
|
|
2023
Q1 | $11 | Hold |
60
| – | – | ﹤0.01% | 876 |
|
|
2022
Q4 | $12 | Hold |
60
| – | – | ﹤0.01% | 818 |
|
|
2022
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 577 |
|
|
2022
Q2 | $0 | Hold |
60
| – | – | ﹤0.01% | 525 |
|
|
2022
Q1 | $0 | Hold |
60
| – | – | ﹤0.01% | 488 |
|
|
2021
Q4 | $0 | Hold |
60
| – | – | ﹤0.01% | 412 |
|
|
2021
Q3 | $0 | Buy |
+60
| New | – | ﹤0.01% | 402 |
|